Home
Posts
Will Pharma’s MFN Deals to Change the Drug-Price Reality for U.S. Patients or European Governments?

Will Pharma’s MFN Deals to Change the Drug-Price Reality for U.S. Patients or European Governments?

And a Health Affairs paper explains how 340B hospitals in 27 states can siphon savings that would otherwise accrue to state Medicaid programs

Jan 8, 2026

Subscribe to Cost Curve Apex to read the rest.

Upgrade to Apex to get access to this post and other subscriber-only content.

No posts found